Nucleotide Analogs - Jena Bioscience

More documents

Recommendations

Info

GST-CTF1 (CCAAT-Box-Binding Transcription Factor 1, activation domain (aa 399-499), GST-tagged) ...................................... PR-798 158 GST-Dr1 (NC2β, 19 kDa, GST-tagged) ................................................. PR-800 169 GST-FXR (Farnesoid-X-activated Receptor, GST-tagged) ................... PR-804 173 GST-LXRα (Liver-X Receptor, α-isoform, GST-tagged) ........................ PR-805 174 GST-LXRα-LBD (Liver-X Receptor, α-isoform, ligand binding domain, GST-tagged) .......................................................................................... PR-807 176 GST-LXRα-N182 (Liver-X Receptor, α-isoform, N-terminal region, GST-tagged) .......................................................................................... PR-813 174 GST-LXRβ (Liver-X Receptor, β-isoform, GST-tagged) ....................... PR-806 175 GST-p53, mt, L22Q and W23S (Tumor Suppressor Protein and Transcription Factor, aa 1-81, GST-tagged) ................................... PR-783 163 GST-p53, wild type (Tumor Suppressor Protein and Transcription Factor, aa 1-81, GST-tagged) ................................... PR-782 162 GST-PPARα (Peroxisome Proliferator-activated Receptor, α-isoform, GST-tagged) ......................................................................... PR-814 176 GST-PPARα-LBD (Peroxisome Proliferator-activated Receptor, α-isoform, ligand binding domain, GST-tagged) .................................... PR-815 176 GST-RAP30 (Transcription Factor IIF, Rap30 subunit, GST-tagged) .... PR-790 154 GST-RAP74 (Transcription Factor IIF, Rap74 subunit, GST-tagged) ... PR-789 153 GST-RARγ (Retinoic Acid Receptor, γ-isoform, GST-tagged) ............... PR-812 178 GST-RPB10 (RNA Polymerase II, RPB10 subunit, GST-tagged) ......... PR-794 157 GST-RPB12 (RNA Polymerase II, RPB12 subunit, GST-tagged) ......... PR-795 157 GST-RPB5 (RNA Polymerase II, p33 subunit, GST-tagged) ................. PR-791 156 GST-RPB6 (RNA Polymerase II, p15.6 subunit, GST-tagged) .............. PR-792 156 GST-RPB9 (RNA Polymerase II, p14.5 subunit, GST-tagged) .............. PR-793 156 GST-RXR-LBD [RXRα (aa 198-462), GST tagged] ............................... PR-801 179 GST-RXRβ (Retinoid X Receptor, β-isoform, GST-tagged) ................... PR-802 179 GST-Sp1 (GC-box Binding Protein, GST-tagged) ................................. PR-799 164 GST-TBP (TATA box Binding Protein, GST-tagged) .............................. PR-781 150 GST-TFIIA (p12) (Transcription Factor IIA, GST tagged γ-subunit) ............................................................................................... PR-786 150 GST-TFIIA (p19) (Transcription Factor IIA, β-subunit, GST-tagged) .... PR-785 150 GST-TFIIA (p55) (Transription Factor IIA, p55 subunit, GST-tagged) ... PR-784 151 GST-TFIIB (Transcription Factor IIB, GSTtagged) ................................ PR-787 151 GST-TFIIEα, p56 (Transcription Factor IIE, α-subunit, GST-tagged) α-subunit, GST-tagged) ......................................................................... PR-788 152 GST-TRα1 (Thyroid Hormone Receptor, α1-isoform, GST-tagged) ....... PR-803 180 GST-VP16 [VP16(411-490), GST-tagged] ............................................. PR-797 161 GsαL ...................................................................................................... PR-501 135 GsαL-Asn295 ........................................................................................ PR-502 135 GsαL-Leu227 ......................................................................................... PR-504 135 GsαL-Leu227-Asn295 ........................................................................... PR-503 135 GsαS ..................................................................................................... PR-505 135 GsαS-Asn280 ........................................................................................ PR-507 135 GsαS-Leu212 ........................................................................................ PR-508 136 GsαS-Leu212-Asn280 ........................................................................... PR-506 136 Gustducin + co-expressed G-protein Gβ1γ2 complex ........................... PR-601 136 Hck SH3 domainGST (hematopoietic tyrosine kinase, SH3 domain)..... PR-336 188 HeLa Cell Cytosol Extract (S100)........................................................... PR-780 181 HeLa Cell Nuclear Extract (for in vitro pre-mRNA splicing) .................... PR-778 181 HeLa Cell Nuclear Extract (for in vitro transcription) .............................. PR-777 181 Histamine H1-Receptor (H1R) .............................................................. PR-614 144 Histamine H1-Receptor (H1R) + co-expressed RGS4 guinea .............. PR-612 143 Histamine H1-Receptor (H1R) guinea.................................................... PR-611 143 Histamine H1-Receptor + RGS4 (H1R) + co-expressed RGS4 ........... PR-615 144 Histamine H2-Receptor (H2R) .............................................................. PR-616 144 Histamine H2-Receptor (H2R) guinea ................................................... PR-613 143 Histamine H2-Receptor + GsαS (H2R + GsαS) .................................... PR-621 145 Histamine H2-Receptor(H2R) ............................................................... PR-620 145 Histamine H2-Receptor-Gqα (H2R-Gqα) .............................................. PR-617 144 Histamine H2-Receptor-GsαL (H2R-GsαL) ........................................... PR-618 144 Histamine H2-Receptor-GsαS (H2R-GsαS) .......................................... PR-619 145 HIV-1 Nef protein (full length, 1-210)His................................................. PR-381 206 HIV-1 Nef protein (full length, myr2-210)His, myristoylated ................... PR-382 206 HIV-1 RT................................................................................................. PR-351 205 HIV-1 RT, p51 subunit............................................................................. PR-353 205 HIV-1 RT, p66 subunit............................................................................. PR-354 205 HIV-1 Vpu-43GST................................................................................... PR-380 205 HIV-2 RT................................................................................................. PR-352 206 HMG1 (High Mobility Group 1 Protein) .................................................. PR-724 170 HMG1 (Native, High Mobility Group 1) .................................................. PR-757 170 H-Ras .................................................................................................... PR-107 127 H-Ras (G12V) ........................................................................................ PR-206 127 H-Ras (G12V)GST ................................................................................ PR-358 127 H-Ras (Q61L) ........................................................................................ PR-203 127 H-Ras ∆C .............................................................................................. PR-201 127 H-Ras ∆C (S17N) .................................................................................. PR-202 127 H-RasGST ............................................................................................. PR-364 127 Importin αHis .......................................................................................... PR-231 148 Importin βHis D. melanogaster............................................................... PR-232 148 Interferon γ (IFNγ) .................................................................................. PR-420 210 Interleukin-1α.......................................................................................... PR-400 209 Interleukin-1β.......................................................................................... PR-401 210 JBS Phosphatase Assay Kit ................................................................... AK-101 199 JNK2α2/SAPK1aHis, active (c-jun kinase2α2/stress-activated protein kinase1a).................................................................................... PR-326 190 K-Ras 4B ............................................................................................... PR-204 128 LCII (Ventricular Myosin Regulatory Light Chain) .................................. PR-393 207 Lck kinase SH3 domainGST (Lymphocyte specifi c kinase, SH3 domain) .......................................................................................... PR-339 189 Lck SH3 domainGST (lymphocyte specifi c kinase, SH3 domain)......... PR-339 203 Leukotriene B4 receptor (BLTR) + co-expressed G-protein Giα1β1γ2 complex.................................................................................. PR-560 142 Leukotriene B4 receptor (BLTR) + co-expressed G-protein Giα2β1γ2 complex ................................................................................ PR-561 142 Leukotriene B4 receptor (BLTR) + co-expressed G-protein Product Index Giα3β1γ2 complex ................................................................................. PR-562 143 LXRα (Liver-X Receptor, α-isoform) ...................................................... PR-744 174 LXRα-LBD (Liver-X Receptor, α-isoform, ligand binding domain) ......... PR-746 175 LXRβ (Liver-X Receptor, β-isoform) ....................................................... PR-745 175 LY294002 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (PI3K-Inhibitor) ....................................................................................... INH-002 187 L-α-Phosphatidyl-(1,2-dipalmitoyl)-D-myo-inositol [Di-C18PtdIns] (PI) .. LI-008 186 L-α-Phosphatidyl-(1,2-dipalmitoyl)-D-myo-inositol-4,5-bisphosphate..... LI-010 186 L-α-Phosphatidyl-(1,2-dipalmitoyl)-D-myo-inositol-4-monophosphate .. LI-009 186 L-α-Phosphatidylcholine (PC)................................................................. LI-004 185 L-α-Phosphatidylethanolamine (PE)....................................................... LI-005 185 L-α-Phosphatidylinositol (PI) .................................................................. LI-001 185 L-α-Phosphatidylinositol-4,5-bisphosphate (PIP2) ................................. LI-003 185 L-α-Phosphatidylinositol-4-phosphate (PIP)........................................... LI-002 185 L-α-Phosphatidylserine (PS) .................................................................. LI-006 186 Membrane Preparation uninfected, ....................................................... PR-634 148 MKK6GST, active (mitogen-activated protein kinase kinase)................. PR-321 194 Mn SODHis,............................................................................................ PR-149 208 Myricetin 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)- 4H-1-benzopyran-4-one (Protein kinase inhibitor) ................................. INH-004 187 native PrPc (full length, residues 23-230)His ......................................... PR-910 203 native PrPc (full length, residues 23-231)His ......................................... PR-908 200 native PrPc (full length, residues 23-231)His ......................................... PR-909 202 native PrPc (globular domain, residues 90-230)His ............................... PR-913 203 native PrPc (globular domain, residues 90-231)His ............................... PR-911 201 native PrPc (globular domain, residues 90-231)His ............................... PR-912 202 NF1-333 (RasGAP) ............................................................................... PR-223 133 Non-muscle Myosin II (Regulatory Light Chain)..................................... PR-394 207 N-Ras ∆C .............................................................................................. PR-205 128 p300 (C1135-2414) (p300 C-terminus, HAT Domain) ........................... PR-770 166 p300 (Tumor Suppressor Protein and Transcription Factor) ................. PR-762 166 p38α/SAPK2aHis, active (stress-activated protein kinase) .................... PR-327 191 p38α/SAPK2aHis, inactive (stress-activated protein kinase) ................. PR-328 191 p42/ERK2/MAPK2His, active (extracellular signal-regulated kinase2/mitogen-activated protein kinase2) ........................................... PR-331 191 p42/ERK2/MAPK2His, inactive (Extracellular signal-regulated Kinase/mitogen-activated protein kinase2) ............................................ PR-320 192 p42/ERK2/MAPK2His, inactive (extracellular signal-regulated kinase2/mitogen-activated protein kinase2) ........................................... PR-332 191 p44/ERK1/MAPK1His, active (extracellular signal-regulated kinase1/mitogen-activated protein kinase1) ........................................... PR-322 192 p44/ERK1/MAPK1His, inactive (extracellular signal-regulated kinase/mitogen-activated protein kinase) ............................................... PR-323 192 p52 (Transcriptional Coactivator) ........................................................... PR-728 166 p53, aa 1-342, C-terminal deletion (Tumor Suppressor Protein and Transcription Factor) .......................... PR-761 162 p53, aa 1-363, C-terminal deletion (Tumor Suppressor Protein and Transcription Factor) .......................... PR-760 162 p53, wild type (Tumor Suppressor Protein and Transcription Factor) ... PR-759 162 p75 (Transcriptional Coactivator and Lens Epithelial Cell- Derived Growth Factor) ......................................................................... PR-729 166 p75-CTR C-terminal region of p75 (LEDGF)] ........................................ PR-758 166 p85α (p85α, Phosphoinositide 3-kinase, regulatory subunit) ................. PR-342 184 PC4 (Positive Cofactor 4, Transcriptional Coactivator, wild type) ......... PR-725 167 PC4-mt (Positive Cofactor 4, Transcriptional Coactivator, F77P mutant) PR-726 167 PC4-mt (Positive Cofactor 4, Transcriptional Coactivator, serine mutations) ................................................................................... PR-727 167 PDGFR-βGST, cytosolic region (Platelet-derived growth factor receptor) ................................................ PR-357 189 PI(3)Kα (Phosphoinositide 3-kinase p110α /p85α)................................. PR-341 S 183 PI(3)Kα (Phosphoinositide 3-kinase p110α /p85α)................................. PR-341 L 183 PI(3)KαGST (Phosphoinositide 3-kinase p110α/p85α)........................... PR-940S 183 PI(3)KαGST (Phosphoinositide 3-kinase p110α/p85α)........................... PR-940L 183 PI(3)KβGST (Phosphoinositide 3-kinase p110β /p85α).......................... PR-344S 183 PI(3)KβGST (Phosphoinositide 3-kinase p110β /p85α).......................... PR-344L 183 PI(3)Kγ His (Phosphoinositide 3-kinase p110γ) ..................................... PR-343S 183 PI(3)Kγ His (Phosphoinositide 3-kinase p110γ) ..................................... PR-343L 183 PI(3)KγHis (Phosphoinositide 3-kinase p110γ/p101) ............................. PR-347S 184 PI(3)KγHis (Phosphoinositide 3-kinase p110γ/p101) ............................. PR-347L 184 PI(3)KγK832RGST, catalytically inactive mutant (Phosphoinositide 3-kinase p110γ)......................................................... PR-346S 184 PI(3)KγK832RGST, catalytically inactive mutant (Phosphoinositide 3-kinase p110γ)......................................................... PR-346L 184 PI(3)KδGST (Phosphoinositide 3-kinase p110δ).................................... PR-345S 184 PI(3)KδGST (Phosphoinositide 3-kinase p110δ).................................... PR-345L 184 PKA substrate peptide GRTGRRNSI ..................................................... PE-208 196 PKAHis, catalytic α-subunit, active (Protein kinase A) ........................... PR-318 194 PKC substrate peptide QKRPSQRSKYL ............................................... PE-209 196 PKCαHis, active (Protein kinase C alpha).............................................. PR-329 194 Platelet Activating Factor Receptor (PAFR) + co-expressed G-protein Giα1β1γ2 complex ................................................................. PR-631 147 Platelet Activating Factor Receptor (PAFR) + co-expressed G-protein Giα1β1γ2 complex ................................................................. PR-632 147 Platelet Activating Factor Receptor (PAFR) + co-expressed G-protein Giα3β1γ2 complex ................................................................. PR-633 147 PPARα (Peroxisome Proliferator-activated Receptor, α-isoform) .......... PR-747 176 PPARβ(δ) (Peroxisome Proliferator-activated Receptor, β-isoform) ..... PR-748 177 PPARγ (Peroxisome proliferator-activated receptor, γ-isoform) ............. PR-749 177 pRB (Retinoblastoma Protein, Tumor Suppressor Protein, Transcription Factor and Proliferation Factor) ....................................... PR-765 163 PRL-3 ..................................................................................................... PR-330 197 Protein kinase CK2, holoenzyme, active (Casein kinase)...................... PR-316 190 Protein kinase CK2, α-subunit, active (Casein kinase) .......................... PR-314 190 Protein kinase CK2, α-subunit, active (Casein kinase) .......................... PR-317 190 Protein kinase CK2, β-subunit (Casein kinase)...................................... PR-315 190 PrPc (A144V)His .................................................................................... PR-374 201 PrPc (F209S)His .................................................................................... PR-372 201 Index 279
Index 280 PrPc (full length, residues 23-230)His.................................................... PR-904 202 PrPc (full length, residues 23-231)His.................................................... PR-902 200 PrPc (full length, residues 23-231)His.................................................... PR-903 202 PrPc (globular domain, residues 90-230)His.......................................... PR-907 203 PrPc (globular domain, residues 90-231)His.......................................... PR-905 201 PrPc (globular domain, residues 90-231)His.......................................... PR-906 202 PrPc (Q228R)His.................................................................................... PR-373 201 PrPc (T194A)His .................................................................................... PR-371 201 PrPc (wild type)His ................................................................................. PR-370 201 PrPcHis Genotyp: ARR (Codons 136,154,171)...................................... PR-376 202 PrPcHis Genotyp: VRQ (Codons 136,154,171) ..................................... PR-377 202 PTEN (phosphatase and tensin homologue deleted on chromosome 10) PR-930 197 PTP 1B (Protein Tyrosine Phosphatase 1B) .......................................... PR-931 197 PTPµ, catalytic domain (D1) (Protein Tyrosine Phosphatase) ............... PR-309 198 PTPµ, cytoplasmic region (D1D2) (Protein Tyrosine Phosphatase)....... PR-349 199 PTP-BL, catalytic domain (Protein Tyrosine Phosphatase-Basophil-like) PR-308 198 PTP-SL-cat, catalytic domain ................................................................. PR-311 198 PTP-SL-ex.............................................................................................. PR-310 198 PTP-SL-ex, inactive (Protein Tyrosine Phosphatase SL)....................... PR-319 198 PTP-SL-kim, kinase interaction motif and catalytic domain (Protein Tyrosine Phosphatase SL)........................................................ PR-312 198 Quercetin 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1benzopyran-4-one (Protein kinase inhibitor) .......................................... INH-003 187 Rab17 .................................................................................................... PR-119 130 Rab17GST-His ...................................................................................... PR-118 130 Rab1AGST-His ...................................................................................... PR-113 128 Rab1BGST-His ...................................................................................... PR-114 128 Rab2 ...................................................................................................... PR-111 128 Rab24 .................................................................................................... PR-121 130 Rab24GST-His ...................................................................................... PR-120 130 Rab27A .................................................................................................. PR-123 130 Rab27AGST-His..................................................................................... PR-122 130 Rab2GST-His ........................................................................................ PR-112 129 Rab3AGST-His ...................................................................................... PR-115 129 Rab4A .................................................................................................... PR-117 129 Rab4AGST-His ...................................................................................... PR-116 129 Rab6A .................................................................................................... PR-109 129 Rab7....................................................................................................... PR-108 129 Rab7GST-His ........................................................................................ PR-362 129 RabGDI ................................................................................................. PR-110 131 Rac1 ∆C ................................................................................................ PR-303 132 RAD51 ................................................................................................... PR-808 164 RafRBD (c-Raf) ...................................................................................... PR-305 189 RafRBD (c-Raf) ..................................................................................... PR-305 133 RafRBDGST (c-Raf) ............................................................................... PR-366 189 RafRBDGST (c-Raf) .............................................................................. PR-366 133 RalGDS-RBDGST ................................................................................. PR-365 132 Ran ........................................................................................................ PR-211 131 Ran (E70A) ............................................................................................ PR-215 131 Ran (G19V/Q69L) ................................................................................. PR-214 131 Ran (Q69L) ............................................................................................ PR-213 131 Ran (T24N) ............................................................................................ PR-212 131 Rap1B ∆C .............................................................................................. PR-301 128 RapGAP-341 ......................................................................................... PR-368 133 RapGAP-341 (R91A) ............................................................................. PR-222 133 RARα (Retinoic Acid Receptor, α-isoform) ............................................ PR-753 177 RARβ (Retinoic Acid Receptor, β-isoform) ............................................ PR-754 177 RARγ (Retinoic Acid Receptor, γ-isoform) ............................................. PR-755 178 RCC1 (RanGEF) .................................................................................... PR-306 132 REP-1His (Rab escort protein)............................................................... PR-105 134 REP-2His (Rab escort protein)............................................................... PR-104 134 Rho A ..................................................................................................... PR-106 132 RhoAGST .............................................................................................. PR-363 132 RhotekinRBDGST ................................................................................. PR-367 133 RNA Pol II (RNA Polymerase II, native complex) .................................. PR-713 154 RNA Pol II-CTD (RNA Polymerase II, carboxyterminal domain) .......... PR-714 155 RNA Pol II-hRPB5 (RNA Polymerase II, p33 subunit) ........................... PR-715 155 RNA Pol II-hRPB9 (RNA Polymerase II, p14.5 subunit) ........................ PR-716 156 Rna1p (RanGAP) .................................................................................. PR-221 133 RXR (Retinoid X receptor) ..................................................................... PR-721 178 RXR-LBD (RXRα, aa 198-462) ............................................................. PR-742 179 RXRβ (Retinoid X Receptor, β-isoform) ................................................ PR-752 178 S100A1................................................................................................... PR-391 207 SC35 (SFRS2 or SRp30b) (Pre-mRNA Splicing Factor) ....................... PR-776 172 SHP-1GST, catalytic domain .................................................................. PR-901 199 Sp1 (GC-box Binding Protein) ............................................................... PR-733 164 Sp1 (GC-box Binding Protein, Natural fraction) .................................... PR-732 163 Sphingomyelin (SM) ............................................................................... LI-007 186 Src kinase SH3 domainGST (Src tyrosine kinase, SH3 domain)........... PR-338 189 Src kinase SH3 domainGST (Src tyrosine kinase, SH3 domain)........... PR-338 203 Src substrate peptide KVEKIGEGTYGVVYK......................................... PE-211 196 SrcGST................................................................................................... PR-900 189 Staurosporine (Protein kinase inhibitor) Streptomyces staurosporeus .. INH-005 187 TBP (TATA box Binding Protein) ............................................................ PR-703 150 TC21/R-Ras2GST ................................................................................. PR-359 128 TFIIA (Transcription Factor IIA, reconstituted) ....................................... PR-731 151 TFIIA-p12 (Transcription Factor IIA, p12 subunit) ................................. PR-701 150 TFIIA-p55 (Transription Factor IIA, p55 subunit) ................................... PR-700 151 TFIIB (Transcription Factor IIB) ............................................................. PR-702 151 TFIID (Transcription Factor IID, native complex) ................................... PR-712 152 TFIIE (Transcription Factor IIE, α- + β-subunits) ................................... PR-706 152 TFIIEα, p56 (Transcription Factor IIE, α-subunit) .................................. PR-704 152 TFIIEβ, p34 (Transcription Factor IIE, β-subunit) .................................. PR-705 152 TFIIF (Transcription Factor IIF, Rap30 + Rap74 subunits) .................... PR-709 153 TFIIF, RAP30 (Transcription Factor IIF, Rap30 subunit) ........................ PR-708 153 TFIIF, RAP74 (Transcription Factor IIF, Rap74 subunit) ........................ PR-707 153 TFIIH (Transcription Factor IIH, native complex) ................................... PR-710 154 http://www.jenabioscience.com TFIIH-p62 (Transcription Factor IIH, p62 subunit) ................................. PR-711 154 Titin, I-band fragment ............................................................................. PR-392 207 Topo I (Human DNA Topoisomerase I, wild type) .................................. PR-735 168 Topo I (Human DNA Topoisomerase I, wild type) .................................. PR-735 170 Topo I (Y723F) (Human DNA Topoisomerase I, Y723F mutant) ........... PR-739 169 Topo I (Y723F) (Human DNA Topoisomerase I, Y723F mutant) ........... PR-739 171 Topo I Core (Human DNA Topoisomerase I, Core Domain)................... PR-737 168 Topo I Core (Human DNA Topoisomerase I, Core Domain) .................. PR-737 171 Topo I CTD (Human DNA Topoisomerase I, C-terminal domain) .......... PR-736 170 Topo I CTD (Human DNA Topoisomerase I, C-terminal domain) ......... PR-736 168 Topo I NTD (Human DNA Topoisomerase I, N-terminal domain) .......... PR-738 168 Topo I NTD (Human DNA Topoisomerase I, N-terminal domain) .......... PR-738 171 TRα1 (Thyroid Hormone Receptor, α1-isoform)..................................... PR-751 180 TRβ1 (Thyroid Hormone Receptor, β1-isoform) ..................................... PR-722 180 Tumor Necrosis Factor α (TNFα) ........................................................... PR-430 210 Tumor Necrosis Factor α (TNFα) ........................................................... PR-431 210 VHR (VH1-related protein tyrosine phosphatase) .................................. PR-350 199 WASP-121GST ..................................................................................... PR-369 134 Wortmannin (PI3K-Inhibitor) Talaromyces wortmannin KY 12420 ......... INH-001 186 WT-1 (+KTS) (The Wilms’ Tumor Suppressor and Transcription/ Pre-mRNA Splicing Factor) .................................................................... PR-766 164 WT-1 (-KTS) (The Wilms’ Tumor Suppressor and Transcription/ Pre-mRNA Splicing Factor) ................................................................... PR-767 165 β1-Adrenergic Receptor (β1AR, Gly389 variant) ................................... PR-521 137 β1-Adrenergic receptor-Arg389-GsαL ................................................... PR-525 137 β1-Adrenergic receptor-Arg389-GsαS ................................................... PR-524 137 β1-Adrenergic receptor-Gly389-GsαL ................................................... PR-522 137 β1-Adrenergic receptor-Gly389-GsαS ................................................... PR-523 137 β2-Adrenergic receptor (β2AR) + co-expressed G-protein GsαL subunit ......................................................................... PR-537 139 β2-Adrenergic receptor (β2AR) + co-expressed G-protein GsαS subunit.......................................................................... PR-548 142 β2-Adrenergic receptorCAM-GsαL ........................................................ PR-531 138 β2-Adrenergic receptor-G16α ............................................................... PR-549 142 β2-Adrenergic receptor-G16α (β2AR-G16α) + co-expressed G-protein Gβ1γ2 complex ..................................................................... PR-550 142 β2-Adrenergic receptor-Giα2 ................................................................. PR-539 139 β2-Adrenergic receptor-Giα2 (β2AR-Giα2) + co-expressed G-protein Gβ1γ2-complex ..................................................................... PR-540 140 β2-Adrenergic receptor-Giα3 ................................................................. PR-541 140 β2-Adrenergic receptor-Giα3 (β2-AR-Giα3) + co-expressed G-protein Gβ1γ2 complex ..................................................................... PR-551 140 β2-Adrenergic receptor-Gqα .................................................................. PR-538 139 β2-Adrenergic receptor-Gqα (β2AR-Gqα) + co-expressed G-protein Gβ1γ2-complex ...................................................................... PR-542 140 β2-Adrenergic receptor-GsαL ................................................................ PR-532 138 β2-Adrenergic receptor-GsαL (β2AR-GsαL) + co-expressed G-protein Gβ1γ2-complex ..................................................................... PR-535 139 β2-Adrenergic receptor-GsαL-Leu227 ................................................... PR-533 138 β2-Adrenergic receptor-GsαL-Leu227-Asn295 ..................................... PR-534 138 β2-Adrenergic receptor-GsαS ............................................................... PR-544 141 β2-Adrenergic receptor-GsαS Leu212 .................................................. PR-547 141 β2-Adrenergic receptor-GsαS Leu212- Asn280 .................................... PR-546 141 β2-Adrenergic receptor-GsαSAsn280 ................................................... PR-545 141 β2-Adrenergic receptor-Gαolf ................................................................ PR-543 140 β2-Adrenergic receptor-TS-GsαL .......................................................... PR-536 139 Enzymes Acc I, L pack ........................................................................................... EN-145L 220 Acc I, S pack .......................................................................................... EN-145S 220 Alkaline Phosphatase, Calf Intestinal (CIP), L pack ............................... EN-161L 229 Alkaline Phosphatase, Calf Intestinal (CIP), S pack............................... EN-161S 229 Alu I, L pack............................................................................................ EN-101L 220 Alu I, S pack ........................................................................................... EN-101S 220 Asu II, L pack.......................................................................................... EN-102L 220 Asu II, S pack ......................................................................................... EN-102S 220 BamH I, L pack ....................................................................................... EN-103L 220 BamH I, S pack ...................................................................................... EN-103S 220 Bcl I, L pack ............................................................................................ EN-104L 220 Bcl I, S pack ........................................................................................... EN-104S................................................................................................. 220 Bgl I, L pack............................................................................................ EN-105L 220 Bgl I, S pack ........................................................................................... EN-105S 220 Bgl II, L pack........................................................................................... EN-106L 220 Bgl II, S pack .......................................................................................... EN-106S 220 BseA I, L pack......................................................................................... EN-107L 220 BseA I, S pack ........................................................................................ EN-107S 220 BseB I, L pack ........................................................................................ EN-108L 220 BseB I, S pack........................................................................................ EN-108S 220 BseC I, L pack ........................................................................................ EN-109L 221 BseC I, S pack........................................................................................ EN-109S 221 BshF I, L pack......................................................................................... EN-110L 221 BshF I, S pack ........................................................................................ EN-110S 221 BsiS I, L pack.......................................................................................... EN-111L 221 BsiS I, S pack ......................................................................................... EN-111S 221 BssA I, L pack......................................................................................... EN-112L 221 BssA I, S pack ........................................................................................ EN-112S 221 BstE II, L pack ........................................................................................ EN-144L 221 BstE II, S pack........................................................................................ EN-144S 221 CspA I, L pack ........................................................................................ EN-113L 221 CspA I, S pack........................................................................................ EN-113S 221 DNA Polymerase I (Klenow), L pack ...................................................... EN-148L 225 DNA Polymerase I (Klenow), S pack...................................................... EN-148S 225 DNase Af, L pack.................................................................................... EN-157L 230 DNase Af, S pack ................................................................................... EN-158S 230 Dpn I, L pack .......................................................................................... EN-160L 221
Page 1 and 2:
JENA BIOSCIENCE Nucleotides and the
Page 3 and 4:
2 Imprint: Design and Layout by: Gr
Page 5 and 6:
Fax Order Form 4 Jena Bioscience Fa
Page 7 and 8:
Terms/Conditions 6 General Business
Page 9 and 10:
8 http://www.jenabioscience.com
Page 11 and 12:
Nucleotide Analogs 10 General Infor
Page 13 and 14:
Nucleotide Analogs 12 Fluorescent C
Page 15 and 16:
Nucleotide Analogs 14 Labeled Amino
Page 17 and 18:
Nucleotide Analogs 16 Labeled Cytid
Page 19 and 20:
Nucleotide Analogs 18 Labeled γ-Am
Page 21 and 22:
Nucleotide Analogs 20 Labeled with
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Nucleotide Analogs 26 Intrinsically
Page 29 and 30:
Nucleotide Analogs 28 Selected refe
Page 31 and 32:
Nucleotide Analogs 30 mant-GTPγS 2
Page 33 and 34:
Nucleotide Analogs 32 http://www.je
Page 35 and 36:
Nucleotide Analogs 34 Labeled Cytid
Page 37 and 38:
Nucleotide Analogs 36 Labeled 8-[(4
Page 39 and 40:
Nucleotide Analogs 38 Non-hydrolyza
Page 41 and 42:
Nucleotide Analogs 40 dATPαS 2‘-
Page 43 and 44:
Nucleotide Analogs 42 Selected refe
Page 45 and 46:
Nucleotide Analogs 44 XTPγS Xantho
Page 47 and 48:
Nucleotide Analogs 46 Bisubstrate I
Page 49 and 50:
Nucleotide Analogs 48 Halogen conta
Page 51 and 52:
Nucleotide Analogs 50 Hei et al. (1
Page 53 and 54:
Nucleotide Analogs 52 Amine-labeled
Page 55 and 56:
Nucleotide Analogs 54 Other Bases
Page 57 and 58:
Nucleotide Analogs 56 dATPαS 2‘-
Page 59 and 60:
Nucleotide Analogs 58 γ-Aminohexyl
Page 61 and 62:
Nucleotide Analogs 60 Adenosine Nuc
Page 63 and 64:
Nucleotide Analogs 62 d4TTP 2’,3
Page 65 and 66:
Nucleotide Analogs 64 6-Thio-GTP 6-
Page 67 and 68:
Nucleotide Analogs 66 Cyclic Nucleo
Page 69 and 70:
Nucleotide Analogs 68 m 7 GTP 7-Met
Page 71 and 72:
Nucleotide Analogs 70 XTP Xanthosin
Page 73 and 74:
Nucleotide Analogs 72 Vial et al. (
Page 75 and 76:
Nucleotide Analogs 74 Non-modifi ed
Page 77 and 78:
Page 79 and 80:
Macromolecular Crystallography 78 C
Page 81 and 82:
Macromolecular Crystallography 80 J
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Macromolecular Crystallography 94 W
Page 97 and 98:
Macromolecular Crystallography 96 O
Page 99 and 100:
Page 101 and 102:
Macromolecular Crystallography 100
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
LEXSY 116 http://www.jenabioscience
Page 119 and 120:
LEXSY 118 http://www.jenabioscience
Page 121 and 122:
LEXSY 120 Secretory expression of t
Page 123 and 124:
LEXSY 122 Synthetic serum- and prot
Page 125 and 126:
LEXSY 124 Important licensing infor
Page 127 and 128:
Recombinant Proteins 126 GTP Signal
Page 129 and 130:
Recombinant Proteins 128 K-Ras 4B h
Page 131 and 132:
Recombinant Proteins 130 Rab17 mous
Page 133 and 134:
Recombinant Proteins 132 Selected r
Page 135 and 136:
Recombinant Proteins 134 WASP-121 G
Page 137 and 138:
Recombinant Proteins 136 G sαS -Le
Page 139 and 140:
Recombinant Proteins 138 Store: -80
Page 141 and 142:
Recombinant Proteins 140 Wenzel-Sei
Page 143 and 144:
Recombinant Proteins 142 Mutation o
Page 145 and 146:
Recombinant Proteins 144 Naunyn- Sc
Page 147 and 148:
Recombinant Proteins 146 Protein co
Page 149 and 150:
Recombinant Proteins 148 Membrane P
Page 151 and 152:
Recombinant Proteins 150 TBP (TATA
Page 153 and 154:
Recombinant Proteins 152 Store: -80
Page 155 and 156:
Recombinant Proteins 154 RAP30 can
Page 157 and 158:
Recombinant Proteins 156 and contai
Page 159 and 160:
Recombinant Proteins 158 BRCA1 (Tum
Page 161 and 162:
Recombinant Proteins 160 Unit defi
Page 163 and 164:
Recombinant Proteins 162 p53, wild
Page 165 and 166:
Recombinant Proteins 164 Sp1 (GC-bo
Page 167 and 168:
Recombinant Proteins 166 p52 (Trans
Page 169 and 170:
Recombinant Proteins 168 Topo I (Hu
Page 171 and 172:
Recombinant Proteins 170 HMG1 (High
Page 173 and 174:
Recombinant Proteins 172 Splicing F
Page 175 and 176:
Recombinant Proteins 174 Lim-Tio et
Page 177 and 178:
Recombinant Proteins 176 GST-LXRα-
Page 179 and 180:
Recombinant Proteins 178 Unit defi
Page 181 and 182:
Recombinant Proteins 180 Purity: >
Page 183 and 184:
Recombinant Proteins 182 PI3 Kinase
Page 185 and 186:
Recombinant Proteins 184 Selected r
Page 187 and 188:
Recombinant Proteins 186 L-α-Phosp
Page 189 and 190:
Recombinant Proteins 188 , Tyrosine
Page 191 and 192:
Recombinant Proteins 190 Purity: >
Page 193 and 194:
Recombinant Proteins 192 p42/ERK2/M
Page 195 and 196:
Recombinant Proteins 194 Akt3/PKBγ
Page 197 and 198:
Recombinant Proteins 196 CK2 substr
Page 199 and 200:
Recombinant Proteins 198 PTP 1B is
Page 201 and 202:
Recombinant Proteins 200 Prion Prot
Page 203 and 204:
Recombinant Proteins 202 Ovine (She
Page 205 and 206:
Recombinant Proteins 204 bovPrPc cD
Page 207 and 208:
Recombinant Proteins 206 HIV-1 Nef
Page 209 and 210:
Recombinant Proteins 208 Antioxidan
Page 211 and 212:
Recombinant Proteins 210 Interleuki
Page 213 and 214:
Enzymes 212 Restriction Enzymes Res
Page 215 and 216:
Enzymes 214 http://www.jenabioscien
Page 217 and 218:
Enzymes 216 Restriction Enzymes Buf
Page 219 and 220:
Enzymes 218 Relative Activity of Re
Page 221 and 222:
Enzymes 220 Acc I 5’...GTMKAC...3
Page 223 and 224:
Enzymes 222 EcoR V 5’...GATATC...
Page 225 and 226:
Enzymes 224 Sca I 5’...AGTACT...3
Page 227 and 228:
Enzymes 226 Selected references: Br
Page 229 and 230: Enzymes 228 GST-RPB9 (RNA Polymeras
Page 231 and 232: Enzymes 230 T4 dNMP kinase Bacterio
Page 233 and 234: Enzymes 232 Topo I Core (Human DNA
Page 235 and 236: 234 http://www.jenabioscience.com
Page 237 and 238: Antibodies 236 Transcription Factor
Page 239 and 240: Antibodies 238 anti-Dr1 rabbit poly
Page 241 and 242: Antibodies 240 PI3 Kinase Antibodie
Page 243 and 244: 242 http://www.jenabioscience.com
Page 245 and 246: PCR related Products 244 Standard P
Page 247 and 248: PCR related Products 246 DNA Mutage
Page 249 and 250: PCR related Products 248 Polymerase
Page 251 and 252: PCR related Products 250 Primers an
Page 253 and 254: PCR related Products 252 DNA Sequen
Page 255 and 256: PCR related Products 254 50 bp DNA
Page 257 and 258: Affi nity Chromatography 256 Immobi
Page 261 and 262: Affi nity Chromatography 260 γ-Ami
Page 265 and 266: Affi nity Chromatography 264 γ-Ami
Page 269 and 270: Affi nity Chromatography 268 2’/3
Page 271 and 272: Index 270 Product Catalog number Pa
Page 273 and 274: Index 272 Labeled 5-Propargylamino-
Page 275 and 276: Index 274 Labeled EDA-ATP + 5-FAM..
Page 277 and 278: Index 276 Labeled γ-Aminooctyl-dUT
Page 279: Index 278 Constitutive LEXSY Starte
Page 283 and 284: Index 282 dPTP, L pack ............
Page 285 and 286: Index 284 Catalog number Product Pa
Page 287 and 288: Index 286 CC-105 JBScreen Cryo 3 ..
Page 289 and 290: Index 288 NU-1014L NTP bundle (larg
Page 291 and 292: Index 290 NU-407S AppNHp (AMPPNP) .
Page 293 and 294: Index 292 NU-810-540Q Labeled EDA-A
Page 295 and 296: Index 294 NU-819L γ-Aminoethyl-App
Page 297 and 298: Index 296 PR-306 RCC1 (RanGEF) ....
show all

Nucleotide Analogs - Jena Bioscience

Create successful ePaper yourself

Delete template?

Save as template?